BOEHRINGER INGELHEIM PHARMACEUTICALS INC. et al v. HEC PHARM CO., LTD. et al > Summary
Court Case Number 2:20-cv-02545
Filing Date May 29, 2020
Termination Date Mar 3, 2021
Court Pennsylvania Eastern District Court
Status Judgment - Judgment on Consent
JudgesWendy Beetlestone
Defendant
Plaintiff Attorneys
6Boehringer Ingelheim International GmbH
Attorney Name: Peter J. Pizzi
Walsh Pizzi O’Reilly Falanga LLP
Boehringer Ingelheim International GmbH
Attorney Name: James F. Hurst
Kirkland & Ellis
Boehringer Ingelheim International GmbH
Attorney Name: Bryan S. Hales
Kirkland & Ellis
Boehringer Ingelheim International GmbH
Attorney Name: Jeanna M. Wacker
Kirkland & Ellis
Boehringer Ingelheim International GmbH
Attorney Name: Mira Atanassova Mulvaney
Kirkland & Ellis
Defendant Attorneys
2HEC Pharm Co., Ltd.
Attorney Name: Stamatios Stamoulis
Stamoulis & Weinblatt
Cause
35:271 Patent Infringement
Related Patents
Doc No | Title | Issue date |
---|---|---|
10034877 | Treatment for diabetes in patients inappropriate for metformin therapy | Jul 31, 2018 |
10022379 | DPP-IV inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation | Jul 17, 2018 |
09415016 | DPP-IV inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation | Aug 16, 2016 |